Search Results 31-40 of 17128 for Glucagon

  1. The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass - Mayo Clinic

    The hypothesis of this study is that increased glucagon-like peptide-1 (GLP-1) secretion explains the amelioration in insulin secretion after Roux-en-Y Gastric ...

  2. Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes - Mayo Clinic

    About this study. The overall goal of this proposal is to determine the effects of acute hyperglycemia and its modulation by Glucagon-like Peptide-1 (GLP-1) ...

  3. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... Glucagon is used in emergency situations when severe symptoms including seizures or ...

  4. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Glucagon is used in emergency situations when severe symptoms such as seizures or unconsciousness occur. Have a glucagon kit available, along with a syringe ...

  5. Dasiglucagon (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Dasiglucagon injection is an emergency medicine used to treat severe hypoglycemia (low blood sugar) in diabetes patients treated with insulin who have passed ...

  6. Publications - W. Brian B. Beam, M.D. - Mayo Clinic

    Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2026 Apr 1 ...

  7. Lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Lixisenatide is used together with diet and exercise to help control your blood sugar. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. This ...

  8. Publications - Michael Jundt, M.D. - Mayo Clinic

    Hepatic steatosis in humans is associated with preserved glucagon action on amino acid metabolism. J Clin Invest. 2026 Mar 2; 136 (5) Epub 2025 Dec 23. View ...

  9. Endocrinology, Diabetes and Metabolism Training Program student roster - Mayo Clinic Research

    Jon David Adams, Ph.D. Adrian Vella, M.D., Understanding the interaction of glucagon and insulin secretion to determine postprandial glucose concentrations in ...

  10. Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists - Mayo Clinic

    ... glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists. Participation eligibility. Participant eligibility ...